Dose-Dependent Changes In Pharmacokinetic And Pharmacodynamic Profiles Of Met409, A Sustained Fxr Agonist, After 12 Weeks Of Treatment In Patients With NashEric J. Lawitz,Kyoung-Jin Lee,Jennifer Shim-Lopez,Jonathan Lee,Hubert C. ChenHEPATOLOGY(2020)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要